AI Assurance
As AI systems become central to business operations, ensuring their reliability and compliance throughout development has become critical. Come explore practical approaches to AI assurance, from early validation workflows to rigorous evaluation and regulatory compliance.
More About the Sharings
Kush Amerasinghe (Founder, BrainBank.world) will share "From Idea to Assured Product - AI-Powered Validation in Practice"
How do you make sure you’re building the right thing before you build it? Kush will show how AI tools can integrate governance and market validation into the earliest stages of product development, from structured ideation with frameworks like the Business Model Canvas to testing demand through AI-generated landing pages. See BrainBank’s idea sandbox in action as a concept moves from rough insight to validated, build-ready output. Discover how responsible innovation can be embedded directly into the builder’s workflow. (Technical Level: 100–200)
Dr. Maximilian Schons (Consultant) will share on “Peregrine Report: Evaluating AI Risk”
Say you are unconstrained by money, and can get all the talent in the world – what are the top interventions that will have a substantial impact over the next 2 years? Max will share research insights from their 2025 Peregrine Report evaluation and auditing track, examining why current benchmarks fall short and what more rigorous, capability-based and reliability-focused AI assurance could look like in practice. (Technical Level: 200)
*Note: Programme is currently being finalised and hence subject to change.
More About the Speakers
Kush Amerasinghe is the founder of BrainBank.world, an AI-powered startup incubator for impact tech founders built on multi-modal and agentic AI systems. He has co-founded pioneering generative AI teams at Adobe and Amazon, bringing diffusion, transformer, and GAN-based products to market. His background spans AI, computer graphics, immersive media, and emerging tech product incubation. Kush has also collaborated with other industry leading organisations including Anthropic, OpenAI, Nvidia, Stability AI, and Microsoft, and has worked across seven countries with a focus on responsible, human-centred AI.
Dr. Maximilian Schons is a physician turned entrepreneur and technical consultant at the intersection of biotechnology and AI. He currently runs his own consultancy focused on responsible innovation in biotechnology and AI assurance, assembling cross-disciplinary teams to tackle complex technical challenges worldwide. Previously, he served as Chief Medical Officer at Alvea, a biotech startup that dosed its first patient just 174 days after founding and co-authored the proposal for Germany’s national pandemic study platform (NAPKON). Based in Germany with a global reach, Max combines medical expertise with research infrastructure development and startup operations experience.
More About the Series
ThursTalks is Lorong AI's curated dialogue series featuring 1 spotlight speaker/theme per session. Each session emphasizes focused perspectives, followed by an extended fireside chat or open discussion to encourage deeper understanding and meaningful exchange of ideas.
Get involved: Lorong AI | Speaker Sign-up | WhatsApp Community | LinkedIn | X